Avid Bioservices Inc (CDMO)

[cjgaddy]

Nice Find, Huts: 11-15-17/Outsourcing-Pharma article (re: SK/RL Interviews)
“How This R&D Company (Peregrine) is Transitioning to a Pure-Play CDMO: ‘Opportunities Are Almost Endless’" - Melissa Fassbender
Recap of interviews with Steve King & Avid Pres. Roger Lias http://tinyurl.com/y7dv9faz
...Excerpt: THE FUTURE AS A CDMO: Lias' 1st objective as the new Pres. of Avid will be to ramp up visibility & bus. dev., he told us. Short term, the strategy is to fully consolidate as a multi-product CDMO. As part of this, the company is currently looking to license or sell its proprietary R&D assets, including Bavituximab. “One of the first things we’ll do is bolster our capabilities for our early phase work,” said Lias. “We need more,” he added. Beyond that, Lias said the next steps will be aligning the organization to be able to better serve multiple clients. The company will grow organically and M&A is, “of course,” a potential, he explained. The company will also look diversify its service offerings and may deploy new “copycat” facilities, though no locations have been chosen at this time. “The opportunities are almost endless out there at the moment,” concluded Lias.
https://muckrack.com/melissa-fassbender